Search results
Your search for XIST returned no results
Showing 16 to 30 of 1558 results for list
Showing 16 to 30 of 1558 results for list
In development Reference number: GID-QS10197 Expected publication date: 27 February 2026
In development Reference number: GID-HST10054 Expected publication date: 20 February 2026
This quality standard covers diagnosing and managing hip fracture in adults (aged 18 and over). It describes high-quality care in priority areas for improvement.
View quality statements for QS16Show all sections
Sections for QS16
- Quality statements
- Quality statement 1: Multidisciplinary management
- Quality statement 2: Timing and expertise for surgery
- Quality statement 3: Intracapsular fracture
- Quality statement 4: Trochanteric fracture
- Quality statement 5: Subtrochanteric fracture
- Quality statement 6: Rehabilitation after surgery
- Update information
See a complete list of all our guidance and quality standards currently open for consultation
Evidence-based recommendations on aflibercept (Eylea) for treating sight problems caused by macular oedema from central retinal vein occlusion in adults.
In development Reference number: GID-TA11385 Expected publication date: 25 February 2026
This quality standard covers renal replacement therapy services for adults with kidney failure. It includes treatment options, such as dialysis and kidney transplant. It describes high-quality care in priority areas for improvement.
View quality statements for QS72Show all sections
Sections for QS72
- Quality statements
- Quality statement 1: Education programmes
- Quality statement 2: Transplantation – pre-emptive
- Quality statement 3: Transplantation – on dialysis
- Quality statement 4: Dialysis access preparation
- Quality statement 5: Home-based dialysis
- Quality statement 6: Patient transport
- Quality statement 7: Transplantation – rapid access to a specialist histopathology service
is the clinical effectiveness of physical activity compared with waiting-list control? Any explanatory notes(if applicable) Why this is...
Evidence-based recommendation on linzagolix (Yselty) for treating symptoms of endometriosis in adults of reproductive age.
Show all sections
Drug-eluting stents for the treatment of coronary artery disease (TA152)
Evidence-based recommendations on using drug-eluting stents in adults.
This quality standard covers assessing, diagnosing and managing physical health problems of adults aged 18 years and older in prisons or young offender institutes. It describes high-quality care in priority areas for improvement.
View quality statements for QS156Show all sections
Sections for QS156
- Quality statements
- Quality statement 1: Medicines reconciliation
- Quality statement 2: Second-stage health assessment
- Quality statement 3: Blood-borne viruses and sexually transmitted infections
- Quality statement 4: Lead care coordinator
- Quality statement 5: Medicines on transfer or discharge
- Update information
- About this quality standard
Epilepsies in children, young people and adults (extraordinary review)
In development Reference number: GID-NG10378 Expected publication date: TBC
In development Reference number: GID-QS10188 Expected publication date: TBC
Bipolar disorder: assessment and management (extraordinary review)
In development Reference number: GID-NG10380 Expected publication date: TBC
Neonatal infection: antibiotics for prevention and treatment - update
In development Reference number: GID-NG10456 Expected publication date: 13 May 2026